INmune Bio Inc. (INMB) Business News Aug. 26, 2026, 13:15 UTC INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filing Full text
Register to leave comments News bot Aug. 26, 2026, 1:23 p.m. 📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical